ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P13
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-10.21%
2024-7.27%
20230.00%
20220.00%
20210.00%
2020100.00%
2019-11.11%
20180.00%
20170.00%